154 related articles for article (PubMed ID: 35697295)
21. An NKp30-based chimeric antigen receptor promotes T cell effector functions and antitumor efficacy in vivo.
Zhang T; Wu MR; Sentman CL
J Immunol; 2012 Sep; 189(5):2290-9. PubMed ID: 22851709
[TBL] [Abstract][Full Text] [Related]
22. The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans.
Brandt CS; Baratin M; Yi EC; Kennedy J; Gao Z; Fox B; Haldeman B; Ostrander CD; Kaifu T; Chabannon C; Moretta A; West R; Xu W; Vivier E; Levin SD
J Exp Med; 2009 Jul; 206(7):1495-503. PubMed ID: 19528259
[TBL] [Abstract][Full Text] [Related]
23. All-trans retinoic acid induces leukemia resistance to NK cell cytotoxicity by down-regulating B7-H6 expression via c-Myc signaling.
Cao G; Cheng Y; Zheng X; Wei H; Tian Z; Sun R; Sun H
Cancer Commun (Lond); 2021 Jan; 41(1):51-61. PubMed ID: 34236140
[TBL] [Abstract][Full Text] [Related]
24. Induction of B7-H6, a ligand for the natural killer cell-activating receptor NKp30, in inflammatory conditions.
Matta J; Baratin M; Chiche L; Forel JM; Cognet C; Thomas G; Farnarier C; Piperoglou C; Papazian L; Chaussabel D; Ugolini S; Vély F; Vivier E
Blood; 2013 Jul; 122(3):394-404. PubMed ID: 23687088
[TBL] [Abstract][Full Text] [Related]
25. The proto-oncogene Myc drives expression of the NK cell-activating NKp30 ligand B7-H6 in tumor cells.
Textor S; Bossler F; Henrich KO; Gartlgruber M; Pollmann J; Fiegler N; Arnold A; Westermann F; Waldburger N; Breuhahn K; Golfier S; Witzens-Harig M; Cerwenka A
Oncoimmunology; 2016 Jul; 5(7):e1116674. PubMed ID: 27622013
[TBL] [Abstract][Full Text] [Related]
26. Beyond Programmed Death-Ligand 1: B7-H6 Emerges as a Potential Immunotherapy Target in SCLC.
Thomas PL; Groves SM; Zhang YK; Li J; Gonzalez-Ericsson P; Sivagnanam S; Betts CB; Chen HC; Liu Q; Lowe C; Chen H; Boyd KL; Kopparapu PR; Yan Y; Coussens LM; Quaranta V; Tyson DR; Iams W; Lovly CM
J Thorac Oncol; 2021 Jul; 16(7):1211-1223. PubMed ID: 33839362
[TBL] [Abstract][Full Text] [Related]
27. Human cytomegalovirus escapes immune recognition by NK cells through the downregulation of B7-H6 by the viral genes US18 and US20.
Charpak-Amikam Y; Kubsch T; Seidel E; Oiknine-Djian E; Cavaletto N; Yamin R; Schmiedel D; Wolf D; Gribaudo G; Messerle M; Cicin-Sain L; Mandelboim O
Sci Rep; 2017 Aug; 7(1):8661. PubMed ID: 28819195
[TBL] [Abstract][Full Text] [Related]
28. B7-H6-mediated downregulation of NKp30 in natural killer cells contributes to HIV-2 immune escape.
Lucar O; Sadjo Diallo M; Bayard C; Samri A; Tarantino N; Debré P; Thiébaut R; Brun-Vézinet F; Matheron S; Cheynier R; Vieillard V;
AIDS; 2019 Jan; 33(1):23-32. PubMed ID: 30325780
[TBL] [Abstract][Full Text] [Related]
29. Tumor Marker B7-H6 Bound to the Coiled Coil Peptide-Polymer Conjugate Enables Targeted Therapy by Activating Human Natural Killer Cells.
Kalousková B; Skořepa O; Cmunt D; Abreu C; Krejčová K; Bláha J; Sieglová I; Král V; Fábry M; Pola R; Pechar M; Vaněk O
Biomedicines; 2021 Nov; 9(11):. PubMed ID: 34829829
[TBL] [Abstract][Full Text] [Related]
30. B7-H6 expression in non-small cell lung cancers.
Zhang X; Zhang G; Qin Y; Bai R; Huang J
Int J Clin Exp Pathol; 2014; 7(10):6936-42. PubMed ID: 25400778
[TBL] [Abstract][Full Text] [Related]
31. Multifunctional NK Cell-Engaging Antibodies Targeting EGFR and NKp30 Elicit Efficient Tumor Cell Killing and Proinflammatory Cytokine Release.
Klausz K; Pekar L; Boje AS; Gehlert CL; Krohn S; Gupta T; Xiao Y; Krah S; Zaynagetdinov R; Lipinski B; Toleikis L; Poetzsch S; Rabinovich B; Peipp M; Zielonka S
J Immunol; 2022 Nov; 209(9):1724-1735. PubMed ID: 36104113
[TBL] [Abstract][Full Text] [Related]
32. Bromodomain protein BRD4 is an epigenetic activator of B7-H6 expression in acute myeloid leukemia.
Baragaño Raneros A; Rodriguez RM; Bernardo Flórez A; Palomo P; Colado E; Minguela A; Suárez Álvarez B; López-Larrea C
Oncoimmunology; 2021 Mar; 10(1):1897294. PubMed ID: 33796404
[TBL] [Abstract][Full Text] [Related]
33.
Liu X; Guo R; Xu Y
Genet Test Mol Biomarkers; 2021 Jul; 25(7):463-470. PubMed ID: 34280008
[No Abstract] [Full Text] [Related]
34. Dual role of B7-H6 as a novel prognostic marker in hepatocellular carcinoma.
Qiu H; Gao S; Sun Z; Wang J
APMIS; 2021 Mar; 129(3):105-117. PubMed ID: 33220098
[TBL] [Abstract][Full Text] [Related]
35. B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape.
Pesce S; Tabellini G; Cantoni C; Patrizi O; Coltrini D; Rampinelli F; Matta J; Vivier E; Moretta A; Parolini S; Marcenaro E
Oncoimmunology; 2015 Apr; 4(4):e1001224. PubMed ID: 26137398
[TBL] [Abstract][Full Text] [Related]
36. NKp30 - A prospective target for new cancer immunotherapy strategies.
Pinheiro PF; Justino GC; Marques MM
Br J Pharmacol; 2020 Oct; 177(20):4563-4580. PubMed ID: 32737988
[TBL] [Abstract][Full Text] [Related]
37. Alterations of the Immunologic Co-Stimulator B7 and TNFR Families Correlate with Hepatocellular Carcinoma Prognosis and Metastasis by Inactivating STAT3.
Li YM; Liu ZY; Li ZC; Wang JC; Yu JM; Yang HJ; Chen ZN; Tang J
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30609841
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of B7-H6 protein expression in astrocytoma.
Guo JG; Guo CC; He ZQ; Liu ZG; Wang Y; Mou YG
Onco Targets Ther; 2016; 9():3291-7. PubMed ID: 27330308
[TBL] [Abstract][Full Text] [Related]
39. High expression of B7-H6 in human glioma tissues promotes tumor progression.
Jiang T; Wu W; Zhang H; Zhang X; Zhang D; Wang Q; Huang L; Wang Y; Hang C
Oncotarget; 2017 Jun; 8(23):37435-37447. PubMed ID: 28415577
[TBL] [Abstract][Full Text] [Related]
40. B7-H6 as an efficient target for T cell-induced cytotoxicity in haematologic malignant cells.
Sun X; Zhao J; Ma L; Sun X; Ge J; Yu Y; Ma J; Zhang M
Invest New Drugs; 2021 Feb; 39(1):24-33. PubMed ID: 32770284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
